These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 23211099)
1. Identification of new potent GPR119 agonists by combining virtual screening and combinatorial chemistry. Wellenzohn B; Lessel U; Beller A; Isambert T; Hoenke C; Nosse B J Med Chem; 2012 Dec; 55(24):11031-41. PubMed ID: 23211099 [TBL] [Abstract][Full Text] [Related]
2. Use of small-molecule crystal structures to address solubility in a novel series of G protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation. Scott JS; Birch AM; Brocklehurst KJ; Broo A; Brown HS; Butlin RJ; Clarke DS; Davidsson O; Ertan A; Goldberg K; Groombridge SD; Hudson JA; Laber D; Leach AG; Macfaul PA; McKerrecher D; Pickup A; Schofield P; Svensson PH; Sörme P; Teague J J Med Chem; 2012 Jun; 55(11):5361-79. PubMed ID: 22545772 [TBL] [Abstract][Full Text] [Related]
3. New potential antihistaminic compounds. Virtual combinatorial chemistry, computational screening, real synthesis, and pharmacological evaluation. Duart MJ; Antón-Fos GM; Alemán PA; Gay-Roig JB; González-Rosende ME; Gálvez J; García-Domenech R J Med Chem; 2005 Feb; 48(4):1260-4. PubMed ID: 15715494 [TBL] [Abstract][Full Text] [Related]
4. From astemizole to a novel hit series of small-molecule somatostatin 5 receptor antagonists via GPCR affinity profiling. Guba W; Green LG; Martin RE; Roche O; Kratochwil N; Mauser H; Bissantz C; Christ A; Stahl M J Med Chem; 2007 Dec; 50(25):6295-8. PubMed ID: 18020391 [TBL] [Abstract][Full Text] [Related]
5. A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors. Tanaka D; Tsuda Y; Shiyama T; Nishimura T; Chiyo N; Tominaga Y; Sawada N; Mimoto T; Kusunose N J Med Chem; 2011 Feb; 54(3):851-7. PubMed ID: 21192659 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists. Budzik BW; Evans KA; Wisnoski DD; Jin J; Rivero RA; Szewczyk GR; Jayawickreme C; Moncol DL; Yu H Bioorg Med Chem Lett; 2010 Feb; 20(4):1363-7. PubMed ID: 20097073 [TBL] [Abstract][Full Text] [Related]
7. Optimization of oxadiazole derivatives with a spirocyclic cyclohexane structure as novel GPR119 agonists. Harada K; Mizukami J; Watanabe T; Mori G; Ubukata M; Suwa K; Fukuda S; Negoro T; Sato M; Inaba T Bioorg Med Chem Lett; 2019 Aug; 29(16):2100-2106. PubMed ID: 31288965 [TBL] [Abstract][Full Text] [Related]
8. Discovery and optimization of 5-(2-((1-(phenylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)oxy)pyridin-4-yl)-1,2,4-oxadiazoles as novel gpr119 agonists. Wang Y; Yu M; Zhu J; Zhang JK; Kayser F; Medina JC; Siegler K; Conn M; Shan B; Grillo MP; Liu JJ; Coward P Bioorg Med Chem Lett; 2014 Feb; 24(4):1133-7. PubMed ID: 24440299 [TBL] [Abstract][Full Text] [Related]
9. Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries. Londregan AT; Piotrowski DW; Futatsugi K; Warmus JS; Boehm M; Carpino PA; Chin JE; Janssen AM; Roush NS; Buxton J; Hinchey T Bioorg Med Chem Lett; 2013 Mar; 23(5):1407-11. PubMed ID: 23337601 [TBL] [Abstract][Full Text] [Related]
10. The synergy between combinatorial chemistry and high-throughput screening. Diller DJ Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors. Jadhav RD; Kadam KS; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Potdar N; Enose AA; Vishwakarma RA; Sivaramakrishnan H; Srinivasan S; Nemmani KV; Gupte A; Gangopadhyay AK; Sharma R Eur J Med Chem; 2012 Aug; 54():324-42. PubMed ID: 22683241 [TBL] [Abstract][Full Text] [Related]
12. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A. Shen HC; Szymonifka MJ; Kharbanda D; Deng Q; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Taggart AK; Wang J; Tong X; Waters MG; Hammond ML; Tata JR; Colletti SL Bioorg Med Chem Lett; 2007 Dec; 17(24):6723-8. PubMed ID: 18029181 [TBL] [Abstract][Full Text] [Related]
13. Discovery and optimization of arylsulfonyl 3-(pyridin-2-yloxy)anilines as novel GPR119 agonists. Zhang JK; Li AR; Yu M; Wang Y; Zhu J; Kayser F; Medina JC; Siegler K; Conn M; Shan B; Grillo MP; Eksterowicz J; Coward P; Liu JJ Bioorg Med Chem Lett; 2013 Jun; 23(12):3609-13. PubMed ID: 23648181 [TBL] [Abstract][Full Text] [Related]